Gene · 3055
Papers2,931
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,931
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Analysis and Validation of a Cancer-associated Fibroblasts Senescence-related Signature for Risk Stratification and Therapeutic Prediction in Esophageal Squamous Cell Carcinoma. | J Cancer | 2024 | 39308671 | PubTator, text mining | PubMed |
| Knockdown of HCK promotes HREC cell viability and inner blood-retinal barrier integrity by regulating the AMPK signaling pathway. | Open Life Sci | 2024 | 39247797 | PubTator, text mining | PubMed |
| [Screening and validation of therapeutic targets for chronic sinusitis with nasal polyps based on proteomics]. | Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi | 2024 | 39107122 | PubTator, text mining | PubMed |
| The Evolving Role of Bruton's Tyrosine Kinase Inhibitors in B Cell Lymphomas. | Int J Mol Sci | 2024 | 39062757 | PubTator, text mining | PubMed |
| Amylose molecular weight affects the complexing state and digestibility of the resulting starch-lipid complexes. | Carbohydr Polym | 2024 | 39048199 | PubTator, text mining | PubMed |
| Abnormal HCK/glutamine/autophagy axis promotes endometriosis development by impairing macrophage phagocytosis. | Cell Prolif | 2024 | 38956970 | PubTator, text mining | PubMed |
| A synergistic mechanism of Liquiritin and Licochalcone B from Glycyrrhiza uralensis against COPD. | Phytomedicine | 2024 | 38870751 | PubTator, text mining | PubMed |
| Recent advances in hematopoietic cell kinase in cancer progression: Mechanisms and inhibitors. | Biomed Pharmacother | 2024 | 38870631 | PubTator, text mining | PubMed |
| Identification and validation of lipid metabolism-related key genes as novel biomarkers in acute myocardial infarction and pan-cancer analysis. | Aging (Albany NY) | 2024 | 38787365 | PubTator, text mining | PubMed |
| Leveraging machine learning models for peptide-protein interaction prediction. | RSC Chem Biol | 2024 | 38725911 | PubTator, text mining | PubMed |
| The BulkECexplorer compiles endothelial bulk transcriptomes to predict functional versus leaky transcription. | Nat Cardiovasc Res | 2024 | 38708406 | PubTator, text mining | PubMed |
| Sphingosine-1-Phosphate Shapes Healthy Monocytes into An Immunosuppressive Phenotype. | Cell Physiol Biochem | 2024 | 38639213 | PubTator, text mining | PubMed |
| Interaction of T-cell-specific adapter protein with Src- and Tec-family kinases. | Scand J Immunol | 2024 | 38605535 | PubTator, text mining | PubMed |
| Identification of potential core genes in pseudoexfoliation using bioinformatics analysis and retrospective analysis of 84 patients with this disease. | Int Ophthalmol | 2024 | 38536501 | PubTator, text mining | PubMed |
| Profiling Key Aroma Compounds of Senecio glaucus L. and their Antimicrobial and Antioxidant Activities: Multiplex of GC-MS, NMR and In Silico Studies. | Chem Biodivers | 2024 | 38531073 | PubTator, text mining | PubMed |
| The dual HCK/BTK inhibitor KIN-8194 impairs growth and integrin-mediated adhesion of BTKi-resistant mantle cell lymphoma. | Leukemia | 2024 | 38454120 | PubTator, text mining | PubMed |
| Identification of neutrophil extracellular trap-driven gastric cancer heterogeneity and C5AR1 as a therapeutic target. | Acta Biochim Biophys Sin (Shanghai) | 2024 | 38425243 | PubTator, text mining | PubMed |
| PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery. | J Chem Inf Model | 2024 | 38404138 | PubTator, text mining | PubMed |
| Pan-cancer proteogenomics characterization of tumor immunity. | Cell | 2024 | 38359819 | PubTator, text mining | PubMed |
| Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents. | Hematol Transfus Cell Ther | 2024 | 38326180 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3055/papers?page=5